NCT06660355 · Interventional trial
Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy
Overall registry status Recruiting
Phase 2
Conditions Chronic Graft-versus-host Disease (cGVHD)
Delaware Valley sites
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory